Articles Archives - Page 487 of 1554 - newsonline.media
Home » Articles » Page 487

Category: Articles

Post
Crossbeats Unveils Blaze B600 Home Theater, Your Gateway to Premium Home Entertainment

Crossbeats Unveils Blaze B600 Home Theater, Your Gateway to Premium Home Entertainment

Crossbeats, a pioneering consumer tech brand renowned for its cutting-edge audio technology, proudly announces the upcoming launch of its latest innovation, the Crossbeats Blaze B600 Home Theatre System. Blaze B600 is poised to revolutionize the home entertainment experience, catering to the growing trend of family movie nights and gaming sessions at home. Pre-booking is available...

Post
Minor Hotels Appoints Puneet Dhawan as Head of Asia

Minor Hotels Appoints Puneet Dhawan as Head of Asia

Global hotel owner and operator Minor Hotels has appointed Puneet Dhawan as Head of Asia as the group plots its growth in Asia and India. From July, Dhawan will be responsible for the performance of all Minor Hotels properties in Asia, working in close collaboration with the Minor Hotels senior leadership team and will report...

Post

Last Chance to Apply for UG and PG Programs at MAHE Bengaluru

Manipal Academy of Higher Education (MAHE), Bengaluru, the esteemed off-campus of MAHE, Manipal, is inviting aspiring students to embark on a transformative academic journey. The admission applications at MAHE is currently being accepted for the academic year 2024-2025 and will be closing soon. Please click on this link to explore the complete list of courses...

Post
Meril’s Next-Gen Myval THV Series Marks India’s Triumph in Global Heart Valve Sector: Successful Primary Outcomes Unveiled at EuroPCR 2024, Garnering Late Breaking Trial Status and Prestigious Acceptance by The LANCET

Meril’s Next-Gen Myval THV Series Marks India’s Triumph in Global Heart Valve Sector: Successful Primary Outcomes Unveiled at EuroPCR 2024, Garnering Late Breaking Trial Status and Prestigious Acceptance by The LANCET

Exciting news from Meril Life Sciences! The LANDMARK trial’s 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was recognized by EuroPCR as one of the top three late breaking trials poised to transform revolutionise current practices in the field of Interventional Cardiology. Myval THV and The LANDMARK The...

Post
TCL India On-boards Rohit Sharma as the Brand Ambassador

TCL India On-boards Rohit Sharma as the Brand Ambassador

TCL – a leading global brand in the Television and Home Appliances segment has recently on-boarded the Indian cricket team captain Rohit Sharma, represented by RISE Worldwide line, as the national brand ambassador to augment its brand presence. By leveraging Sharma’s goodwill in the market and his association with the most popular sport in the...

Post
Celebrating The Goodness of Walnuts

Celebrating The Goodness of Walnuts

Despite three months of scorching heat, summer is full of reasons to celebrate. From the beautiful sunshine, the temptation of seasonal fruits and vegetables, and, of course, international and national food days to keep you in a celebratory mood all season long even though the current health situation may make you feel otherwise. An annual...

Post
Co-founder S.D. Shibulal’s Family Sell Shares of Infosys Limited

Co-founder S.D. Shibulal’s Family Sell Shares of Infosys Limited

Today, Mr. S.D. Shibulal (Co-founder and Former CEO, Infosys Limited) announced that his one of his family members has sold a portion of their holding in Infosys Limited on the stock exchanges yesterday. S.D. Shibulal The sale was executed by Cholamandalam Securities Limited as the Sole Broker. The co-founders have nurtured the company for over...

Post

Grant Thornton Bharat Acts as Exclusive Advisor to Biorad Medisys for its Fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II

Biorad Medisys Pvt. Limited (“Biorad Medisys”), a leading medical device manufacturer in India, recently completed another round of funding, raising INR 400 crore from Kotak Strategic Situations India Fund II (“KSSF II”) managed by Kotak Alternate Asset Managers Ltd. (KAAML). This bolsters Biorad Medisys’ financial standing and marks an exit for their existing investor, DMI...